Neurophth Therapeutics completes patient enrollment in phase I/II clinical trial of esonadogene mvoparvovec
EyePod: Modifier Gene Therapy: What is it?
Ophthalmology in paradise
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
Washington University researcher receives $300,000 grant to study AMD
Insight: A focus on fellows’ training and challenging glaucoma surgical cases
2 Commerce Drive Cranbury, NJ 08512